Sernova Corp.

‘His expertise in the islands also complements the other SAB members who are experts in the field of diabetes, Sertoli Sertoli cells. ‘.. Sernova Corp.: appointed islet cell Pioneer To Advance Sertolin Diabetes Therapy HelpSernova Corp. is pleased that world class, pancreatic islet cells expert transplant, Shinichi Matsumoto, Director known of Baylor All Saints Islet Cell Laboratory at Baylor Research Institute in Fort Worth Texas an appointment an appointment Sernova Scientific Advisory Board . Matsumoto a pioneer in a pioneer in human islet transplantation for diabetes. He has many remarkable achievements in the field of islet transplantation, which will assist Sernova in pursuing its clinical regulatory path for the future. His research has resulted in numerous scientific publications on islet isolation, preparation and transplantation.

About SernovaSernova Corp. Is a Canadian-based, insulin-dependent diabetes working on commercializing medical technologies and currently working on a novel treatment of insulin-dependent diabetes specialist with its patented Sertolin cell technology. According to the American Diabetes Association approximately 9 million Americans require insulin injections and it is the sixth leading cause of death in the United States.Related Articles published The Times on Monday well as three products about the treatment and diagnosis of diabetes. Care Management: ‘Despite the fact show that nearly 20 percent all health care dollars growing for the management of people with diabetes, the diabetes epidemic and associated pain and grow grow, ‘said John buses, president of Mitte Scientific and medicine to the American Diabetes Association buses Buse offered five pieces out of information that any diabetic should (New York Times..